In contrast to these data however, numerous studies reveal PD-L1 expression was associated with poor prognosis and overall survival (OS) in solid cancers, such as head and neck squamous cell carcinoma (HNSCC) (71), breast cancer (72), non-small cell lung cancer (NSCLC) (73) and bladder cancer (74). The gene discussed is CD274; the disease is urinary bladder cancer.